Literature DB >> 15626806

Switching prescription drugs to over the counter.

Joshua P Cohen1, Cherie Paquette, Catherine P Cairns.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15626806      PMCID: PMC539854          DOI: 10.1136/bmj.330.7481.39

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  OTC statins: a bad decision for public health.

Authors: 
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

2.  Switching omeprazole in Sweden and the United States.

Authors:  Joshua Cohen
Journal:  Am J Ther       Date:  2003 Sep-Oct       Impact factor: 2.688

  2 in total
  19 in total

1.  Switching prescription drugs to over the counter: consumers may benefit financially in examples from the US.

Authors:  Patrick W Sullivan
Journal:  BMJ       Date:  2005-04-16

2.  Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumers.

Authors:  Martin Duerden; Tom Walley
Journal:  BMJ       Date:  2005-04-16

3.  Switching prescription drugs to over the counter: willingness to buy statin over the counter is not related to risk of heart disease.

Authors:  Jerry Quill; Richard Martin
Journal:  BMJ       Date:  2005-04-16

4.  Switching prescription drugs to over the counter: over the counter licensing is linked to direct to consumer advertising.

Authors:  Robert G Bunney
Journal:  BMJ       Date:  2005-04-16

5.  Switching prescription drugs to over the counter: chicken and egg scenario is possible.

Authors:  Magnus Hird
Journal:  BMJ       Date:  2005-04-16

6.  Over the counter medicines: proceed with caution.

Authors:  Robin E Ferner; Keith Beard
Journal:  BMJ       Date:  2008-03-29

7.  Over-the-counter orlistat: early experiences, views and attitudes of community pharmacists in Great Britain.

Authors:  Anita Elaine Weidmann; Scott Cunningham; Gwen Gray; Denise Hansford; James McLay; John Broom; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2011-05-15

8.  Transatlantic convergence with respect to the fourth hurdle?

Authors:  Joshua Cohen
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

9.  Results of a national survey on over-the-counter medicines, Part 1: Pharmacist opinion on current scheduling status.

Authors:  Jeff Taylor; Eric Landry; Lyne Lalonde; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2012-01

10.  Pharmacists' perceived integration into practice of over-the-counter simvastatin five years post reclassification.

Authors:  Vibhu Paudyal; Denise Hansford; Scott Cunningham; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2012-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.